Breaking Angel Reese Shines in Atlanta Dream’s Record-Breaking Victory Over Los Angeles Sparks Malnutrition Fuels Stunting Crisis Among Benin’s Young Children US and South Korea Conclude Military Drills Early Amid North Korean Tensions Japan Executes Man Convicted in 2009 Osaka Pachinko Parlor Fire U.S. Intensifies Economic Pressure on Iran Amid Warnings of “Economic D-Day”

Friday August 21, 2026

Reporter

Creative Medical Technology Holdings, Inc.

2Articles Published

4Communities Covered

Published Articles

Press Release

Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning

18 hours ago

Press Release

Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms

Aug 6